FTXH

First Trust Nasdaq Pharmaceuticals ETF · NAS

  • Category Health Care
  • Expense Ratio 0.6%
  • Listing Date Sep 21, 2016
  • Volume 2,078.0
  • Market Cap (AUM) $14.84M

Performance

-1.76%

1W

-0.1%

1M

-7.53%

3M

+1.17%

6M

+3.0%

YTD

+6.19%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Pfizer Inc.PFE7.60%
  • Merck & Co., Inc.MRK7.43%
  • AbbVie, Inc.ABBV6.91%
  • Johnson & JohnsonJNJ6.58%
  • Bristol-Myers Squibb CompanyBMY5.97%
  • Eli Lilly and CompanyLLY4.28%
  • United Therapeutics CorporationUTHR4.22%
  • Vertex Pharmaceuticals IncorporatedVRTX4.16%
  • Amgen Inc.AMGN3.98%
  • Biogen Inc.BIIB3.94%

Technical Analysis of FTXH 2024-12-20

The stock's indicators reflect a bearish sentiment overall, with a Moving Average Score of 10 indicating strong downward momentum, a neutral Oscillators Score of 50 suggesting indecision, and a Technical Score of 30 reinforcing the bearish outlook. This combination signals caution for potential investors as the market appears to be leaning towar...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.